Aurinia Pharmaceuticals
AUPH
#5402
Rank
NZ$1.94 B
Marketcap
$13.60
Share price
-2.26%
Change (1 day)
42.11%
Change (1 year)

Revenue for Aurinia Pharmaceuticals (AUPH)

Revenue in 2024 (TTM): NZ$0.35 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is NZ$0.38 Billion. In 2023 the company made a revenue of NZ$0.27 Billion an increase over the revenue in the year 2022 that were of NZ$0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aurinia Pharmaceuticals from 1999 to 2024

20002005201020152020$0.1B$0.2B$0.3B$0.4B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.35 B28.35%
2023 NZ$0.27 B31.47%
2022 NZ$0.21 B216.18%
2021 NZ$66.76 M-3.88%
2020 NZ$69.45 M14610.57%
2019 NZ$0.47 M-31.59%
2018 NZ$0.69 M17%
2017 NZ$0.58 M136.22%
2016 NZ$0.24 M-27.26%
2015 NZ$0.34 M-3.23%
2014 NZ$0.35 M-69.3%
2013 NZ$1.15 M-84.35%
2012 NZ$7.38 M509.62%
2011 NZ$1.21 M-72.57%
2010 NZ$4.41 M16.68%
2009 NZ$3.78 M-43.88%
2008 NZ$6.74 M134.23%
2007 NZ$2.87 M-41.43%
2006 NZ$4.91 M-1068.94%
2005 -NZ$0.51 Million-129.19%
2004 NZ$1.73 M-85.26%
2003 NZ$11.79 M-49.18%
2002 NZ$23.21 M
2000 NZ$2.01 M-22.65%
1999 NZ$2.59 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$24.18 B 6,183.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.03 M-97.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.18 M-91.12%๐Ÿ‡บ๐Ÿ‡ธ USA